Poseida Therapeutics slips, launches equity offering after stock surges
03/08/2022 21:20
** Poseida Therapeutics Inc's PSTX.O shares surrendering
some gains post-market, falling ~14%, as co looks to raise
equity
** PSTX surged 85.6% to close at $4.51 on Weds after co
inked deal with Roche ROG.S to develop therapies for blood
tissue cancers urn:newsml:reuters.com:*:nL4N2ZF2ZM
** After the bell, genetic engineering firm commences share
offering; deal size not disclosed urn:newsml:reuters.com:*:nPn2r4yFYa
** Piper Sandler, William Blair, Cantor Fitzgerald and BTIG
acting as bookrunners
** Co has ~62.7 mln shares for roughly ~$280 mln market cap,
per Refinitiv data, and ~37.1 mln shares of free float
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))